Bioinformatics Analyses Reveal the Prognostic Value and Biological Roles of SEPHS2 in Various Cancers

References

• International Agency for Research on Cancer [homepage on the Internet]. Latest global cancer data: cancer burden rises to 19.3 million new cases and 10.0 million cancer deaths in 2020; 2020. Available from: https://www.iarc.who.int/news-events/latest-global-cancer-data-cancer-burden-rises-to-19-3-million-new-cases-and-10-0-million-cancer-deaths-in-2020/. Accessed July 3, 2021.
   Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231–1251. doi:10.1093/neuonc/noab106
   PubMed Web of Science ®Google Scholar
• Rayman MP. Selenium and human health. Lancet. 2012;379(9822):1256–1268. doi:10.1016/S0140-6736(11)61452-9
   PubMed Web of Science ®Google Scholar
• Hossain A, Skalicky M, Brestic M, et al. Selenium biofortification: roles, mechanisms, responses and prospects. Molecules. 2021;26(4):881. doi:10.3390/molecules26040881
   PubMed Web of Science ®Google Scholar
• Gladyshev VN, Arner ES, Berry MJ, et al. Selenoprotein gene nomenclature. J Biol Chem. 2016;291(46):24036–24040. doi:10.1074/jbc.M116.756155
   PubMed Web of Science ®Google Scholar
• Xu XM, Carlson BA, Mix H, et al. Biosynthesis of selenocysteine on its tRNA in eukaryotes. PLoS Biol. 2007;5(1):e4. doi:10.1371/journal.pbio.0050004
   PubMed Web of Science ®Google Scholar
• Labunskyy VM, Hatfield DL, Gladyshev VN. Selenoproteins: molecular pathways and physiological roles. Physiol Rev. 2014;94(3):739–777. doi:10.1152/physrev.00039.2013
   PubMed Web of Science ®Google Scholar
• Turanov AA, Xu XM, Carlson BA, Yoo MH, Gladyshev VN, Hatfield DL. Biosynthesis of selenocysteine, the 21st amino acid in the genetic code, and a novel pathway for cysteine biosynthesis. Adv Nutr. 2011;2(2):122–128. doi:10.3945/an.110.000265
   PubMed Web of Science ®Google Scholar
• Tujebajeva RM, Copeland PR, Xu XM, et al. Decoding apparatus for eukaryotic selenocysteine insertion. EMBO Rep. 2000;1(2):158–163. doi:10.1093/embo-reports/kvd033
   PubMed Web of Science ®Google Scholar
• Xu XM, Carlson BA, Irons R, et al. Selenophosphate synthetase 2 is essential for selenoprotein biosynthesis. Biochem J. 2007;404(1):115–120. doi:10.1042/BJ20070165
   PubMed Web of Science ®Google Scholar
• Kim IY, Guimaraes MJ, Zlotnik A, Bazan JF, Stadtman TC. Fetal mouse selenophosphate synthetase 2 (SPS2): characterization of the cysteine mutant form overproduced in a baculovirus-insect cell system. Proc Natl Acad Sci U S A. 1997;94(2):418–421. doi:10.1073/pnas.94.2.418
   PubMed Web of Science ®Google Scholar
• Hughes DJ, Duarte-Salles T, Hybsier S, et al. Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort. Am J Clin Nutr. 2016;104(2):406–414. doi:10.3945/ajcn.116.131672
   PubMed Web of Science ®Google Scholar
• Hughes DJ, Fedirko V, Jenab M, et al. Selenium status is associated with colorectal cancer risk in the European prospective investigation of cancer and nutrition cohort. Int J Cancer. 2015;136(5):1149–1161. doi:10.1002/ijc.29071
   PubMed Web of Science ®Google Scholar
• Hervouet E, Staehlin O, Pouliquen D, et al. Antioxidants delay clinical signs and systemic effects of ENU induced brain tumors in rats. Nutr Cancer. 2013;65(5):686–694. doi:10.1080/01635581.2013.789541
   PubMed Web of Science ®Google Scholar
• Yakubov E, Eibl T, Hammer A, Holtmannspotter M, Savaskan N, Steiner HH. Therapeutic Potential of selenium in glioblastoma. Front Neurosci. 2021;15:666679. doi:10.3389/fnins.2021.666679
   PubMed Web of Science ®Google Scholar
• Short SP, Williams CS. Selenoproteins in tumorigenesis and cancer progression. Adv Cancer Res. 2017;136:49–83.
   PubMed Web of Science ®Google Scholar
• Liu Q, Jin J, Ying J, et al. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma. Int J Mol Sci. 2015;16(5):10636–10649. doi:10.3390/ijms160510636
   PubMed Web of Science ®Google Scholar
• Carlisle AE, Lee N, Matthew-Onabanjo AN, et al. Selenium detoxification is required for cancer-cell survival. Nat Metab. 2020;2(7):603–611. doi:10.1038/s42255-020-0224-7
   PubMedGoogle Scholar
• Fedirko V, Jenab M, Meplan C, et al. Association of Selenoprotein and selenium pathway genotypes with risk of colorectal cancer and interaction with selenium status. Nutrients. 2019;11:4. doi:10.3390/nu11040935
   Web of Science ®Google Scholar
• Nunziata C, Polo A, Sorice A, et al. Structural analysis of human SEPHS2 protein, a selenocysteine machinery component, over-expressed in triple negative breast cancer. Sci Rep. 2019;9(1):16131. doi:10.1038/s41598-019-52718-0
   PubMed Web of Science ®Google Scholar
• Uhlen M, Fagerberg L, Hallstrom BM, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419. doi:10.1126/science.1260419
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya S, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–658. doi:10.1016/j.neo.2017.05.002
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi:10.1093/nar/gkx247
   PubMed Web of Science ®Google Scholar
• Zhao Z, Zhang KN, Wang Q, et al. Chinese Glioma Genome Atlas (CGGA): a comprehensive resource with functional genomic data from Chinese glioma patients. Genomics Proteomics Bioinformatics. 2021. doi:10.1016/j.gpb.2020.10.005
   Web of Science ®Google Scholar
• Chalmers ZR, Connelly CF, Fabrizio D, et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med. 2017;9(1):34. doi:10.1186/s13073-017-0424-2
   PubMed Web of Science ®Google Scholar
• Buttner R, Longshore JW, Lopez-Rios F, et al. Implementing TMB measurement in clinical practice: considerations on assay requirements. ESMO Open. 2019;4(1):e442. doi:10.1136/esmoopen-2018-000442
   PubMed Web of Science ®Google Scholar
• Bonneville R, Krook MA, Kautto EA, et al. Landscape of microsatellite instability across 39 cancer types. Jco Precision Oncol. 2017;3(1):1–15. doi:10.1200/PO.17.00073
   Web of Science ®Google Scholar
• Sturm G, Finotello F, List M. Immunedeconv: an R package for unified access to computational methods for estimating immune cell fractions from Bulk RNA-Sequencing Data. Methods Mol Biol. 2020;2120:223–232.
   PubMedGoogle Scholar
• Racle J, Gfeller D. EPIC: a tool to estimate the proportions of different cell types from bulk gene expression data. Methods Mol Biol. 2020;2120:233–248.
   PubMedGoogle Scholar
• Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509–W514. doi:10.1093/nar/gkaa407
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–D613. doi:10.1093/nar/gky1131
   PubMed Web of Science ®Google Scholar
• Jiang T, Shi T, Zhang H, et al. Tumor neoantigens: from basic research to clinical applications. J Hematol Oncol. 2019;12(1):93. doi:10.1186/s13045-019-0787-5
   PubMed Web of Science ®Google Scholar
• Lan X, Xing J, Gao H, et al. Decreased expression of selenoproteins as a poor prognosticator of gastric cancer in humans. Biol Trace Elem Res. 2017;178(1):22–28. doi:10.1007/s12011-016-0908-8
   PubMed Web of Science ®Google Scholar
• Jia Y, Dai J, Zeng Z. Potential relationship between the selenoproteome and cancer. Mol Clin Oncol. 2020;13(6):83. doi:10.3892/mco.2020.2153
   PubMed Web of Science ®Google Scholar
• Papp LV, Lu J, Holmgren A, Khanna KK. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal. 2007;9(7):775–806. doi:10.1089/ars.2007.1528
   PubMed Web of Science ®Google Scholar
• Squires JE, Stoytchev I, Forry EP, Berry MJ. SBP2 binding affinity is a major determinant in differential selenoprotein mRNA translation and sensitivity to nonsense-mediated decay. Mol Cell Biol. 2007;27(22):7848–7855. doi:10.1128/MCB.00793-07
   PubMed Web of Science ®Google Scholar
• Donovan J, Caban K, Ranaweera R, Gonzalez-Flores JN, Copeland PR. A novel protein domain induces high affinity selenocysteine insertion sequence binding and elongation factor recruitment. J Biol Chem. 2008;283(50):35129–35139. doi:10.1074/jbc.M806008200
   PubMed Web of Science ®Google Scholar
• Howard MT, Copeland PR. New directions for understanding the codon redefinition required for selenocysteine incorporation. Biol Trace Elem Res. 2019;192(1):18–25. doi:10.1007/s12011-019-01827-y
   PubMed Web of Science ®Google Scholar
• Louis DN. Molecular pathology of malignant gliomas. Annu Rev Pathol. 2006;1:97–117. doi:10.1146/annurev.pathol.1.110304.100043
   PubMed Web of Science ®Google Scholar
• Furnari FB, Fenton T, Bachoo RM, et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 2007;21(21):2683–2710. doi:10.1101/gad.1596707
   PubMed Web of Science ®Google Scholar
• Gimple RC, Bhargava S, Dixit D, Rich JN. Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer. Genes Dev. 2019;33(11–12):591–609. doi:10.1101/gad.324301.119
   PubMed Web of Science ®Google Scholar
• Le Rhun E, Preusser M, Roth P, et al. Molecular targeted therapy of glioblastoma. Cancer Treat Rev. 2019;80:101896. doi:10.1016/j.ctrv.2019.101896
   PubMed Web of Science ®Google Scholar
• Lv S, Luo H, Huang K, Zhu X. The prognostic role of glutathione peroxidase 1 and immune infiltrates in glioma investigated using public datasets. Med Sci Monit. 2020;26:e926440. doi:10.12659/MSM.926440
   PubMed Web of Science ®Google Scholar
• Chan TA, Yarchoan M, Jaffee E, et al. Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic. Ann Oncol. 2019;30(1):44–56. doi:10.1093/annonc/mdy495
   PubMed Web of Science ®Google Scholar
• Samstein RM, Lee CH, Shoushtari AN, et al. Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat Genet. 2019;51(2):202–206. doi:10.1038/s41588-018-0312-8
   PubMed Web of Science ®Google Scholar
• Ott PA, Hu Z, Keskin DB, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 2017;547(7662):217–221. doi:10.1038/nature22991
   PubMed Web of Science ®Google Scholar
• Schumacher TN, Schreiber RD. Neoantigens in cancer immunotherapy. Science. 2015;348(6230):69–74. doi:10.1126/science.aaa4971
   PubMed Web of Science ®Google Scholar
• Chang L, Chang M, Chang HM, Chang F. Microsatellite Instability: a predictive biomarker for cancer immunotherapy. Appl Immunohistochem Mol Morphol. 2018;26(2):e15–e21. doi:10.1097/PAI.0000000000000575
   PubMedGoogle Scholar
• Andre T, Shiu KK, Kim TW, et al. Pembrolizumab in Microsatellite-instability-high advanced colorectal cancer. N Engl J Med. 2020;383(23):2207–2218.
   PubMed Web of Science ®Google Scholar
• Avery JC, Hoffmann PR. Selenium, Selenoproteins, and Immunity. Nutrients. 2018;10(9):1203. doi:10.3390/nu10091203
   PubMed Web of Science ®Google Scholar
• Razaghi A, Poorebrahim M, Sarhan D, Bjornstedt M. Selenium stimulates the antitumour immunity: insights to future research. Eur J Cancer. 2021;155:256–267. doi:10.1016/j.ejca.2021.07.013
   PubMed Web of Science ®Google Scholar
• Santi A, Kugeratski FG, Zanivan S. Cancer associated fibroblasts: the architects of stroma remodeling. Proteomics. 2018;18(5–6):e1700167. doi:10.1002/pmic.201700167
   PubMed Web of Science ®Google Scholar
• Michalik L, Desvergne B, Wahli W. Peroxisome-proliferator-activated receptors and cancers: complex stories. Nat Rev Cancer. 2004;4(1):61–70. doi:10.1038/nrc1254
   PubMed Web of Science ®Google Scholar
• Sertznig P, Seifert M, Tilgen W, Reichrath J. Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer. J Cell Physiol. 2007;212(1):1–12. doi:10.1002/jcp.20998
   PubMed Web of Science ®Google Scholar
• Gandhi UH, Kaushal N, Ravindra KC, et al. Selenoprotein-dependent up-regulation of hematopoietic prostaglandin D2 synthase in macrophages is mediated through the activation of peroxisome proliferator-activated receptor (PPAR) gamma. J Biol Chem. 2011;286(31):27471–27482. doi:10.1074/jbc.M111.260547
   PubMed Web of Science ®Google Scholar
• Shi Y, Zou Y, Shen Z, et al. Trace Elements, PPARs, and metabolic syndrome. Int J Mol Sci. 2020;21(7):2612. doi:10.3390/ijms21072612
   PubMed Web of Science ®Google Scholar
• Diwakar BT, Korwar AM, Paulson RF, Prabhu KS. The regulation of pathways of inflammation and resolution in immune cells and cancer stem cells by selenium. Adv Cancer Res. 2017;136:153–172.
   PubMed Web of Science ®Google Scholar